标题
Dipeptidyl Peptidase-4 Inhibitors for the Treatment of Type 2 Diabetes Mellitus
作者
关键词
-
出版物
PHARMACOTHERAPY
Volume 30, Issue 5, Pages 463-484
出版商
Wiley
发表日期
2010-04-23
DOI
10.1592/phco.30.5.463
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Saxagliptin: a new dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes
- (2009) Carolyn F. Deacon et al. ADVANCES IN THERAPY
- Saxagliptin: a new DPP-4 inhibitor for the treatment of type 2 diabetes mellitus
- (2009) Abd A. Tahrani et al. ADVANCES IN THERAPY
- Comment on: Torii et al. (2009) Gene Silencing of Phogrin Unveils Its Essential Role in Glucose-Responsive Pancreatic -Cell Growth. Diabetes 58:682-692
- (2009) Y. Hu et al. DIABETES
- From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus
- (2009) R. A. DeFronzo DIABETES
- The Efficacy and Safety of Saxagliptin When Added to Metformin Therapy in Patients With Inadequately Controlled Type 2 Diabetes With Metformin Alone
- (2009) R. A. DeFronzo et al. DIABETES CARE
- Saxagliptin given in combination with metformin as initial therapy improves glycaemic control in patients with type 2 diabetes compared with either monotherapy: a randomized controlled trial
- (2009) M. Jadzinsky et al. DIABETES OBESITY & METABOLISM
- Pharmacokinetics of the Dipeptidyl Peptidase 4 Inhibitor Saxagliptin in Rats, Dogs, and Monkeys and Clinical Projections
- (2009) A. Fura et al. DRUG METABOLISM AND DISPOSITION
- Effect of Sitagliptin on the Pharmacokinetics of Simvastatin
- (2009) Arthur J. Bergman et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Differential chemistry (structure), mechanism of action, and pharmacology of GLP-1 receptor agonists and DPP-4 inhibitors
- (2009) Joshua J. Neumiller JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION
- Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials
- (2009) Kausik K Ray et al. LANCET
- Rhabdomyolysis Caused by a Potential Sitagliptin-Lovastatin Interaction
- (2009) Robert V DiGregorio et al. PHARMACOTHERAPY
- Prevalence, Treatment, and Control of Diagnosed Diabetes in the U.S. National Health and Nutrition Examination Survey 1999–2004
- (2008) Kwok Leung Ong et al. ANNALS OF EPIDEMIOLOGY
- Sitagliptin, an dipeptidyl peptidase-4 inhibitor, does not alter the pharmacokinetics of the sulphonylurea, glyburide, in healthy subjects
- (2008) Goutam C. Mistry et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Dipeptidyl Peptidase-4 as a New Target of Action for Type 2 Diabetes Mellitus: A Systematic Review
- (2008) Javaid H. Wani et al. CARDIOLOGY CLINICS
- Pharmacokinetics, pharmacodynamics, and tolerability of single increasing doses of the dipeptidyl peptidase-4 inhibitor alogliptin in healthy male subjects
- (2008) R CHRISTOPHER et al. CLINICAL THERAPEUTICS
- Pharmacokinetic, pharmacodynamic, and tolerability profiles of the dipeptidyl peptidase-4 inhibitor alogliptin: A randomized, double-blind, placebo-controlled, multiple-dose study in adult patients with type 2 diabetes
- (2008) P COVINGTON et al. CLINICAL THERAPEUTICS
- Efficacy and safety of sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes
- (2008) Itamar Raz et al. CURRENT MEDICAL RESEARCH AND OPINION
- Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes
- (2008) D. M. Nathan et al. DIABETES CARE
- Efficacy and Safety of the Dipeptidyl Peptidase-4 Inhibitor Alogliptin in Patients With Type 2 Diabetes and Inadequate Glycemic Control: A randomized, double-blind, placebo-controlled study
- (2008) R. A. DeFronzo et al. DIABETES CARE
- Looking to the Future Focus on DPP-4 Inhibitors for the Treatment of Type 2 Diabetes and Emerging Therapies
- (2008) Joshua J. Neumiller et al. DIABETES EDUCATOR
- Efficacy and tolerability of vildagliptin in drug-nave patients with type 2 diabetes and mild hyperglycaemia
- (2008) W. A. Scherbaum et al. DIABETES OBESITY & METABOLISM
- Efficacy and safety of sitagliptin when added to ongoing metformin therapy in patients with type 2 diabetes*
- (2008) R. Scott et al. DIABETES OBESITY & METABOLISM
- Glucose-lowering activity of the dipeptidyl peptidase-4 inhibitor saxagliptin in drug-naive patients with type 2 diabetes
- (2008) J. Rosenstock et al. DIABETES OBESITY & METABOLISM
- Safety and efficacy of sitagliptin in patients with type 2 diabetes and chronic renal insufficiency
- (2008) J. C. N. Chan et al. DIABETES OBESITY & METABOLISM
- Efficacy and safety of sitagliptin in the treatment of patients with type 2 diabetes in China, India, and Korea
- (2008) Viswanathan Mohan et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Comparison of vildagliptin and acarbose monotherapy in patients with Type 2 diabetes: a 24-week, double-blind, randomized trial
- (2008) C. Pan et al. DIABETIC MEDICINE
- Vildagliptin
- (2008) Jamie D Croxtall et al. DRUGS
- Pharmacokinetic, pharmacodynamic, and efficacy profiles of alogliptin, a novel inhibitor of dipeptidyl peptidase-4, in rats, dogs, and monkeys
- (2008) Bumsup Lee et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Janumet™: a combination product suitable for use in patients with Type 2 diabetes
- (2008) Jonathan Kent Reynolds et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Efficacy and safety of adding the dipeptidyl peptidase-4 inhibitor alogliptin to metformin therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy: a multicentre, randomised, double-blind, placebo-controlled study
- (2008) M. A. Nauck et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Paget's Disease of the Mandible
- (2008) Mayank B. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
- (2008) Rury R. Holman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Emergency Contraception: A Reasonable Personal Choice or a Destructive Societal Influence?
- (2007) M F Greene CLINICAL PHARMACOLOGY & THERAPEUTICS
- Postmenopausal Hormone Therapy for Disease Prevention: Have We Learned Any Lessons from the Past?
- (2007) J E Rossouw CLINICAL PHARMACOLOGY & THERAPEUTICS
- Vildagliptin, a Novel Dipeptidyl Peptidase IV Inhibitor, Has No Pharmacokinetic Interactions With the Antihypertensive Agents Amlodipine, Valsartan, and Ramipril in Healthy Subjects
- (2007) Yan-Ling He et al. JOURNAL OF CLINICAL PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More